Addiction Treatment - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509246887

Publication Date:

September 18, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Drug addiction is a chronic, recurrent disease characterized by the uncontrolled application of an addictive drug. In recent years, the abuse of exogenous opioids (such as morphine and heroin) has become a serious social problem. It does not care about the physical and mental health of the abuser himself. It also has disastrous consequences for families and society. Opioid withdrawal is extremely difficult once it is abused.
The global market for Addiction Treatment was estimated to be worth US$ 3288.8 million in 2023 and is forecast to a readjusted size of US$ 4285 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Addiction Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Addiction Treatment by region & country, by Type, and by Application.
The Addiction Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Addiction Treatment.
麻豆原创 Segmentation
By Company
Cipla
Allergan
Alkermes
Pfizer
Orexo
GlaxoSmithKiline
Purdue Pharma
Mallinckrodt
Reckitt Benckiser
Segment by Type:
Alcohol Addiction Treatment
Tobacco/Nicotine Addiction Treatment
Tobacco/Nicotine Addiction Treatment
Other Substance Addiction Treatment
Segment by Application
Outpatient Treatment Center
Residential Treatment Center
Inpatient Treatment Center
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Addiction Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Addiction Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Addiction Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Addiction Treatment Product Introduction
1.2 Global Addiction Treatment 麻豆原创 Size Forecast
1.3 Addiction Treatment 麻豆原创 Trends & Drivers
1.3.1 Addiction Treatment Industry Trends
1.3.2 Addiction Treatment 麻豆原创 Drivers & Opportunity
1.3.3 Addiction Treatment 麻豆原创 Challenges
1.3.4 Addiction Treatment 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Addiction Treatment Players Revenue Ranking (2023)
2.2 Global Addiction Treatment Revenue by Company (2019-2024)
2.3 Key Companies Addiction Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Addiction Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Addiction Treatment
2.6 Addiction Treatment 麻豆原创 Competitive Analysis
2.6.1 Addiction Treatment 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Addiction Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Addiction Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Alcohol Addiction Treatment
3.1.2 Tobacco/Nicotine Addiction Treatment
3.1.3 Tobacco/Nicotine Addiction Treatment
3.1.4 Other Substance Addiction Treatment
3.2 Global Addiction Treatment Sales Value by Type
3.2.1 Global Addiction Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Addiction Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Addiction Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Outpatient Treatment Center
4.1.2 Residential Treatment Center
4.1.3 Inpatient Treatment Center
4.2 Global Addiction Treatment Sales Value by Application
4.2.1 Global Addiction Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Addiction Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Addiction Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Addiction Treatment Sales Value by Region
5.1.1 Global Addiction Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Addiction Treatment Sales Value by Region (2019-2024)
5.1.3 Global Addiction Treatment Sales Value by Region (2025-2030)
5.1.4 Global Addiction Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Addiction Treatment Sales Value, 2019-2030
5.2.2 North America Addiction Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Addiction Treatment Sales Value, 2019-2030
5.3.2 Europe Addiction Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Addiction Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Addiction Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Addiction Treatment Sales Value, 2019-2030
5.5.2 South America Addiction Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Addiction Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Addiction Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Addiction Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Addiction Treatment Sales Value
6.3 United States
6.3.1 United States Addiction Treatment Sales Value, 2019-2030
6.3.2 United States Addiction Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Addiction Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Addiction Treatment Sales Value, 2019-2030
6.4.2 Europe Addiction Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Addiction Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Addiction Treatment Sales Value, 2019-2030
6.5.2 China Addiction Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Addiction Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Addiction Treatment Sales Value, 2019-2030
6.6.2 Japan Addiction Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Addiction Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Addiction Treatment Sales Value, 2019-2030
6.7.2 South Korea Addiction Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Addiction Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Addiction Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Addiction Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Addiction Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Addiction Treatment Sales Value, 2019-2030
6.9.2 India Addiction Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Addiction Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Cipla
7.1.1 Cipla Profile
7.1.2 Cipla Main Business
7.1.3 Cipla Addiction Treatment Products, Services and Solutions
7.1.4 Cipla Addiction Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Cipla Recent Developments
7.2 Allergan
7.2.1 Allergan Profile
7.2.2 Allergan Main Business
7.2.3 Allergan Addiction Treatment Products, Services and Solutions
7.2.4 Allergan Addiction Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Allergan Recent Developments
7.3 Alkermes
7.3.1 Alkermes Profile
7.3.2 Alkermes Main Business
7.3.3 Alkermes Addiction Treatment Products, Services and Solutions
7.3.4 Alkermes Addiction Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Pfizer Recent Developments
7.4 Pfizer
7.4.1 Pfizer Profile
7.4.2 Pfizer Main Business
7.4.3 Pfizer Addiction Treatment Products, Services and Solutions
7.4.4 Pfizer Addiction Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Pfizer Recent Developments
7.5 Orexo
7.5.1 Orexo Profile
7.5.2 Orexo Main Business
7.5.3 Orexo Addiction Treatment Products, Services and Solutions
7.5.4 Orexo Addiction Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Orexo Recent Developments
7.6 GlaxoSmithKiline
7.6.1 GlaxoSmithKiline Profile
7.6.2 GlaxoSmithKiline Main Business
7.6.3 GlaxoSmithKiline Addiction Treatment Products, Services and Solutions
7.6.4 GlaxoSmithKiline Addiction Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 GlaxoSmithKiline Recent Developments
7.7 Purdue Pharma
7.7.1 Purdue Pharma Profile
7.7.2 Purdue Pharma Main Business
7.7.3 Purdue Pharma Addiction Treatment Products, Services and Solutions
7.7.4 Purdue Pharma Addiction Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Purdue Pharma Recent Developments
7.8 Mallinckrodt
7.8.1 Mallinckrodt Profile
7.8.2 Mallinckrodt Main Business
7.8.3 Mallinckrodt Addiction Treatment Products, Services and Solutions
7.8.4 Mallinckrodt Addiction Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Mallinckrodt Recent Developments
7.9 Reckitt Benckiser
7.9.1 Reckitt Benckiser Profile
7.9.2 Reckitt Benckiser Main Business
7.9.3 Reckitt Benckiser Addiction Treatment Products, Services and Solutions
7.9.4 Reckitt Benckiser Addiction Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Reckitt Benckiser Recent Developments
8 Industry Chain Analysis
8.1 Addiction Treatment Industrial Chain
8.2 Addiction Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Addiction Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Addiction Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Cipla
Allergan
Alkermes
Pfizer
Orexo
GlaxoSmithKiline
Purdue Pharma
Mallinckrodt
Reckitt Benckiser

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.